EUVIMEDEUVIMED entdecken
Crossref

Characteristics and predictive values of super-responders in alopecia areata under tofacitinib treatment: a single-centre retrospective study

Ruxin Ji, Jundong Huang, Jia Jian, Min Li iD, Ji Li, Yan Tang, Wei Shi

Clinical and Experimental Dermatology · 2025

DOI: 10.1093/ced/llaf131 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Dermatology, 2025. Verfasst von Ruxin Ji und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Xiangya Hospital, Central South University, Hu Nan Key Laboratory of Aging Biology, Changsha, China. Hauptthemen laut MEDLINE: Alopecia Areata, Pyrimidines, Janus Kinase Inhibitors, Piperidines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: China National Postdoctoral Program for Innovative Talents, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Alopecia areata (AA) is an autoimmune disorder characterized by nonscarring hair loss, significantly impacting patients’ quality of life. Rapid hair regrowth is the primary goal of treatment, particularly for super-responders (SRs), who demonstrate remarkable and swift improvement. The advent of Janus kinase (JAK) inhibitor treatment has transformed AA management, yet predictors of SRs in AA remain underexplored.

Objectives

This study aimed to characterize SRs among patients with AA treated with tofacitinib, identify clinical and demographic predictors of SRs, and analyse treatment outcomes over 12 months.

Methods

We conducted a single-centre, longitudinal retrospective analysis of 80 patients with AA treated with tofacitinib at Xiangya Hospital, Central South University, Changsha, China, from February 2021 to August 2024. Patients were classified as SRs if they achieved a ≥ 80% reduction in the Severity of Alopecia Tool (SALT) score by the 3rd month or a 100% reduction (SALT100) by the 6th month. Clinical data, treatment outcomes and potential predictors of SR status were analysed using binary logistic regression.

Results

SRs comprised 37.5% of the cohort. Significant predictors of SR status included older age and the absence of prior JAK inhibitor treatment. Female patients and those without previous corticosteroid use also trended towards higher SR rates, although these factors were not statistically significant. SRs demonstrated faster and more sustained hair regrowth, with 93% achieving SALT100 by 6 months, compared with 42% of non-SRs at 12 months.

Conclusions

To our knowledge, this study is the first to define and characterize SRs in patients with AA treated with a JAK inhibitor, providing a reference for dermatologists to optimize AA management. Identifying SRs early may improve patient outcomes and inform treatment strategies, particularly in those with a history of JAK inhibitor use. Further research is warranted to validate these findings in larger, multicentre cohorts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alopecia AreataPyrimidinesJanus Kinase InhibitorsPiperidinesProtein Kinase InhibitorsHumansRetrospective StudiesFemaleMaleAdultMiddle AgedTreatment OutcomeLongitudinal StudiesYoung AdultSeverity of Illness IndexAge FactorsChinaAdolescent

Substanzen

tofacitinibPyrimidinesJanus Kinase InhibitorsPiperidinesProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Department of Dermatology, Xiangya Hospital, Central South University, Hu Nan Key Laboratory of Aging Biology, Changsha, China.

ORCID-Profile: Min Li

Förderung

  • China National Postdoctoral Program for Innovative Talents
  • National Natural Science Foundation of China

Zitieren

APA

Ji, R., Huang, J., Jian, J., Li, M., Li, J., Tang, Y., & Shi, W. (2025). Characteristics and predictive values of super-responders in alopecia areata under tofacitinib treatment: a single-centre retrospective study. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llaf131

Vancouver

Ji R, Huang J, Jian J, Li M, Li J, Tang Y, et al. Characteristics and predictive values of super-responders in alopecia areata under tofacitinib treatment: a single-centre retrospective study. Clinical and Experimental Dermatology. 2025. doi:10.1093/ced/llaf131

BibTeX
@article{Ji2025,
  author = {Ji, Ruxin and Huang, Jundong and Jian, Jia and Li, Min and Li, Ji and Tang, Yan and Shi, Wei},
  title = {Characteristics and predictive values of super-responders in alopecia areata under tofacitinib treatment: a single-centre retrospective study},
  journal = {Clinical and Experimental Dermatology},
  year = {2025},
  doi = {10.1093/ced/llaf131}
}
Kostenlos starten →